Skip to Main Content

Author Details

Gary P Kobinger
University of Texas Medical Branch
1997
305
61
PMIDPaper TitleJournal TitlePublished Year
36828503Human and Livestock Surveillance Revealed the Circulation of Rift Valley Fever Virus in Agnam, Northern Senegal, 2021.Trop Med Infect Dis2023
37670783BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine.iScience2023
37596837Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting.J Infect Dis2023
37652070From private incentives to public health need: rethinking research and development for pandemic preparedness.Lancet Glob Health2023
37649434Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.Emerg Microbes Infect2023
37871706Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles.J Virol Methods2023
37053583Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells.ACS Infect Dis2023
37347931Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13.CRISPR J2023
37243081Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.Vaccines (Basel)2023
37474155Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus-Infected Rhesus Macaques.J Infect Dis2023
36655944SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants.Emerg Microbes Infect2023
34626109Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques.J Infect Dis2022
35474311Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters.NPJ Vaccines2022
35817815SARS-CoV-2 molecular diagnosis at airports to minimize travel-related COVID-19 spread.Sci Rep2022
35563619Ebola Virus Encodes Two microRNAs in Huh7-Infected Cells.Int J Mol Sci2022
35850366An adaptable platform for in-house hepatitis C serology.J Virol Methods2022
36543794A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines.NPJ Vaccines2022
36277085Texas professionals are employing a one health approach to protect the United States against biosecurity threats.One Health2022
35902675Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic.Sci Rep2022
36268900Multiple genotypes of Crimean-Congo hemorrhagic fever virus detected in ticks during a one health survey in Agnam, Northeastern Senegal.Emerg Microbes Infect2022
36289776A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice.Biomedicines2022
36288065Crimean-Congo Hemorrhagic Fever Virus Survey in Humans, Ticks, and Livestock in Agnam (Northeastern Senegal) from February 2021 to March 2022.Trop Med Infect Dis2022
36003947Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines.Front Microbiol2022
35287095The road to effective and accessible antibody therapies against Ebola virus.Curr Opin Virol2022
35251051Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection.Front Immunol2022
34791300Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia.J Infect Dis2022
33387757Computational genomics of Torque teno sus virus and Porcine circovirus in swine samples from Canada.Res Vet Sci2021
33652895Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment.Microorganisms2021
33925854Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.Microorganisms2021
33616976Testing for the presence of SARS-CoV-2 RNA in presymptomatic blood donors.Transfusion2021
33615041SARS-CoV-2 spillover transmission due to recombination event.Gene Rep2021
33917562Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus.Int J Mol Sci2021
34525286Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.N Engl J Med2021
34521922In vivo generation of collagen specific Tregs with AAV8 suppresses autoimmune responses and arthritis in DBA1 mice through IL10 production.Sci Rep2021
344638772021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2021
34576803Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe.Microorganisms2021
34572372Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models.Biomedicines2021
34774358A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.Vaccine2021
34385382Plant-made vaccines and therapeutics.Science2021
33968948The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.Front Med (Lausanne)2021
34011553Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1.J Virol2021
33217364Vaccine innovation spurred by the long wait for an Ebola virus vaccine.Lancet Infect Dis2021
33159902Modeling host-feeding preference and molecular systematics of mosquitoes in different ecological niches in Canada.Acta Trop2021
33446825Gut microbiota modulation induced by Zika virus infection in immunocompetent mice.Sci Rep2021
309428842017 Outbreak of Ebola Virus Disease in Northern Democratic Republic of Congo.J Infect Dis2020
32052030Mosquito Species Composition and Abundance in Quebec, Eastern Canada.J Med Entomol2020
31952924Safety and immunogenicity of vesicular stomatitis virus-based vaccines for Ebola virus disease.Lancet Infect Dis2020
31799896Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.Hum Vaccin Immunother2020
33370366COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study.PLoS One2020
33219792Hantavirus Cardiopulmonary Syndrome in Canada.Emerg Infect Dis2020
  • 1 - 50 of 305

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 13
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 2
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year 2012
Number of shared co-authors 9
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 3
University of Maryland
Career Start Year 2009
Number of shared co-authors 2
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 4
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 7
Rutgers University
Career Start Year 2007
Number of shared co-authors 3
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 1
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 4
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 7
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 6
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 9
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 15
Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 13
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 15
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 7
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 10
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 15
Saint Louis University School of Medicine
Career Start Year 1992
Number of shared co-authors 8
University of North Carolina at Chapel Hill.
Career Start Year 1990
Number of shared co-authors 14
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 13
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 21
University of North Carolina
Career Start Year 1981
Number of shared co-authors 21
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 6

Collaborators

University of Manitoba
Co-authored papers 30
Wistar Institute
Co-authored papers 20
Italian Ministry of Health
Co-authored papers 18
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 16
Section of Emergency Medicine,University of Nebraska Medical Center
Co-authored papers 15
Co-authored papers 14
University of Pretoria
Co-authored papers 14
Co-authored papers 11
National Institute of Biomedical Research (INRB)
Co-authored papers 9
Washington University School of Medicine at St. Louis
Co-authored papers 9
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Institut National de Recherche Biomedicale
Co-authored papers 8
University of Pretoria
Co-authored papers 6
Institute of Virology, Philipps University
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 6
Christchurch Hospital
Co-authored papers 5
Co-authored papers 5
Influenza Research Institute, University of Wisconsin
Co-authored papers 5
The Fenway Institute
Co-authored papers 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 5
Harvard University
Co-authored papers 5
University of Texas Medical Branch at Galveston
Co-authored papers 5
Institute of Virology, Philipps University Marburg
Co-authored papers 5
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
London School of Hygiene & Tropical Medicine
Co-authored papers 4